635530356	635530356	CD	B-NP	O
|	|	NNP	I-NP	O
CH	CH	NNP	I-NP	O
|	|	VBD	B-VP	O
15575070	15575070	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9783438	9783438	CD	B-NP	O
|	|	CC	I-NP	O
3/30/2006	3/30/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/30/2006	3/30/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/13/2006	10/13/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
POPHAM	POPHAM	NN	B-NP	O
,	,	,	O	O
JOAQUIN	JOAQUIN	NN	B-NP	O
297-63-44-8	297-63-44-8	CD	I-NP	O
Sterltongo	Sterltongo	NNP	I-NP	O
Verarvchatrasquite	Verarvchatrasquite	NNP	I-NP	O
Ge	Ge	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
7/12/06	7/12/06	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FENCHEL	FENCHEL	NNP	B-NP	O
,	,	,	O	O
CARROLL	CARROLL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
CPR	CPR	NN	I-NP	B-protein
,	,	,	O	O
No	No	DT	B-NP	O
defib	defib	NN	I-NP	O
,	,	,	O	O
No	No	DT	B-NP	O
intubation	intubation	NN	I-NP	O
,	,	,	O	O
No	No	DT	B-NP	O
pressors	pressor	NNS	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/30/06	4/30/06	CD	B-NP	O
by	by	IN	B-PP	O
DEZAN	DEZAN	NNP	B-NP	O
,	,	,	O	O
SANDY	SANDY	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
MULTIVITAMIN	MULTIVITAMIN	NN	B-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
267794658	267794658	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
March	March	NNP	I-NP	O
LOVENOX	LOVENOX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
March	March	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
continue	continue	VB	B-VP	O
until	until	IN	B-PP	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
>	>	JJR	B-NP	O
2.0	2.0	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	B-VP	O
stop	stop	VB	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
FOLIC	FOLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
HYDRALAZINE	HYDRALAZINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

ATROVENT	ATROVENT	NNP	B-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Wheezing	Wheezing	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
90	90	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
X	X	SYM	O	I-protein
14	14	CD	B-NP	I-protein
Days	Day	NNPS	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
March	March	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

LISINOPRIL	LISINOPRIL	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/15/06	10/15/06	CD	B-NP	O
by	by	IN	B-PP	O
GORSLINE	GORSLINE	NNP	B-NP	O
,	,	,	O	O
MICKEY	MICKEY	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
879934878	879934878	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/15/06	10/15/06	CD	B-NP	O
by	by	IN	B-PP	O
BACCHUS	BACCHUS	NNP	B-NP	O
,	,	,	O	O
CHAD	CHAD	NNP	B-NP	O
O.	O.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
305325324	305325324	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
awaer	awaer	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/12/06	3/12/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	NNP	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/19/06	10/19/06	CD	B-NP	O
by	by	IN	B-PP	O
FAIRALL	FAIRALL	NNP	B-NP	O
,	,	,	O	O
HOMER	HOMER	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
716833501	716833501	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/19/06	10/19/06	CD	B-NP	O
by	by	IN	B-PP	O
LANGBEIN	LANGBEIN	NN	B-NP	B-protein
,	,	,	O	O
VINCENT	VINCENT	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
898970113	898970113	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/2/06	6/2/06	CD	B-NP	O
by	by	IN	B-PP	O
BELFORD	BELFORD	NNP	B-NP	O
,	,	,	O	O
KEITH	KEITH	NNP	B-NP	O
I.	I.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
276164057	276164057	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/2/06	6/2/06	CD	B-NP	O
by	by	IN	B-PP	O
NOIA	NOIA	NNP	B-NP	O
,	,	,	O	O
KENNY	KENNY	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
429817272	429817272	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/30/06	4/30/06	CD	B-NP	O
by	by	IN	B-PP	O
BRADMON	BRADMON	NNP	B-NP	O
,	,	,	O	O
DONOVAN	DONOVAN	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
267828811	267828811	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
PM	PM	NNP	I-NP	O
March	March	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVI	MULTIVI	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/30/06	4/30/06	CD	B-NP	O
by	by	IN	B-PP	O
DITTEMORE	DITTEMORE	NN	B-NP	O
,	,	,	O	O
FELTON	FELTON	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
THIAMINE	THIAMINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
TORSEMIDE	TORSEMIDE	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
March	March	NNP	I-NP	O
TRAZODONE	TRAZODONE	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Insomnia	Insomnia	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3	3	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/12/06	7/12/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Turneer	Turneer	NNP	I-NP	O
,	,	,	O	O
cardiology	cardiology	NN	B-NP	O
10/21/06	10/21/06	CD	I-NP	O
2	2	CD	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
PM	PM	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Parsi	Parsi	NNP	I-NP	O
,	,	,	O	O
Sskin	Sskin	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
call	call	VB	B-VP	O
him	him	PRP	B-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
this	this	DT	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
1/25/06	1/25/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
MMH	MMH	NNP	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
by	by	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
initially	initially	RB	B-ADVP	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
bph	bph	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
copd	copd	NN	I-NP	O
-LRB-	-LRB-	SYM	B-VP	O
fev1	fev1	NN	B-NP	O
1.4	1.4	CD	I-NP	O
L	L	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
right	right	JJ	I-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	VBP	B-VP	O
alcohol	alcohol	NN	B-NP	O
abuse	abuse	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
alcohol	alcohol	NN	I-NP	B-protein
abuse	abuse	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
ischemic	ischemic	JJ	I-NP	I-protein
cardiomyopathy	cardiomyopathy	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
cardiomyopathy	cardiomyopathy	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
cardiomyopathy	cardiomyopathy	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
coronary	coronary	JJ	I-NP	I-protein
artery	artery	NN	I-NP	I-protein
disease	disease	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
coronary	coronary	JJ	I-NP	I-protein
artery	artery	NN	I-NP	I-protein
disease	disease	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
diabetes	diabetes	NN	I-NP	I-protein
mellitus	mellitus	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
diabetes	diabetes	NN	I-NP	I-protein
mellitus	mellitus	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
chf	chf	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
diuresis	diuresis	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
cc	cc	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
***	***	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
73	73	CD	B-NP	O
yo	yo	NN	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
NSCLCa	NSCLCa	NN	B-NP	O
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
CMP	CMP	NN	I-NP	O
with	with	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
for	for	IN	B-PP	O
48-72	48-72	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Well	Well	RB	B-ADVP	O
over	over	IN	B-PP	O
weekend	weekend	NN	B-NP	O
.	.	.	O	O

Admits	Admit	NNS	B-NP	O
to	to	TO	B-PP	O
missing	miss	VBG	B-VP	O
torsemide	torsemide	NN	B-NP	O
yesterday	yesterday	NN	B-NP	O
.	.	.	O	O

Baseline	Baseline	NNP	B-NP	O
ADLS	ADLS	NNP	I-NP	O
and	and	CC	O	O
climb	climb	NN	B-NP	O
one	one	CD	I-NP	O
flight	flight	NN	I-NP	O
stairs	stair	NNS	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
pillow	pillow	NN	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
.	.	.	O	O

Unable	Unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
sleep	sleep	VB	I-VP	O
o/n	o/n	RP	B-PRT	O
secondary	secondary	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
.	.	.	O	O
?	?	.	O	O

1	1	CD	B-NP	O
month	month	NN	I-NP	O
R	R	NN	I-NP	O
LEE	LEE	NN	I-NP	O
.	.	.	O	O

***	***	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
ICMP	ICMP	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
EF	EF	NN	I-NP	O
25-30	25-30	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
cyper	cyper	NN	B-NP	O
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
9/21	9/21	CD	I-NP	I-protein
,	,	,	O	O
cypher	cypher	NN	B-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
4/3	4/3	CD	I-NP	I-protein
,	,	,	O	O
NSLCa	NSLCa	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Stage	Stage	NNP	I-NP	O
IIIA	IIIA	NNP	I-NP	O
small	small	JJ	I-NP	O
cell	cell	NN	I-NP	O
CA	CA	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
BPH	BPH	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
COPD	COPD	NN	B-NP	O
fev1	fev1	NN	I-NP	O
1.4	1.4	CD	I-NP	O
L	L	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
***	***	SYM	I-NP	O
Meds	Med	NNPS	I-NP	O
-	-	HYPH	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
80	80	CD	I-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
75	75	CD	I-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
325	325	CD	I-NP	O
,	,	,	O	O
folic	folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
hydral	hydral	JJ	B-NP	O
50	50	CD	I-NP	O
TID	TID	NN	I-NP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
50	50	CD	I-NP	O
,	,	,	O	O
MVI	MVI	NN	B-NP	O
,	,	,	O	O
thiamine	thiamine	NN	B-NP	O
100	100	CD	I-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
imdur	imdur	NN	B-NP	O
90	90	CD	I-NP	O
,	,	,	O	O
trazadone	trazadone	NN	B-NP	O
25	25	CD	I-NP	O
,	,	,	O	O
ambien	ambien	IN	B-ADVP	O
5	5	CD	B-NP	O
,	,	,	O	O
nexium	nexium	NN	B-NP	O
,	,	,	O	O
mvi	mvi	NN	B-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
***	***	SYM	I-NP	O
allgy	allgy	NN	I-NP	O
-	-	HYPH	B-NP	O
NKDA	NKDA	NN	I-NP	B-protein
***	***	SYM	O	O
Status	Status	NNP	B-NP	O
PERRL	PERRL	NNP	I-NP	O
,	,	,	O	O
EOMI	EOMI	NNP	B-NP	O
,	,	,	O	O
anicteric	anicteric	JJ	B-ADJP	O
,	,	,	O	O
OP	OP	NNP	B-NP	O
clear	clear	JJ	I-NP	O
Supple	Supple	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-ADVP	O
thyromegaly	thyromegaly	RB	I-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
2	2	CD	I-NP	I-protein
+	+	SYM	I-NP	O
carotids	carotid	NNS	I-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	O
10-12	10-12	CD	I-NP	O
cm	cm	NN	I-NP	O
R	R	NN	I-NP	O
:	:	:	O	O
crackles	crackle	NNS	B-NP	O
base	base	NN	I-NP	O
Left	Left	NNP	I-NP	O
:	:	:	O	O
very	very	RB	B-NP	O
decreased	decrease	VBN	I-NP	O
BS	BS	NN	I-NP	O
throughout	throughout	IN	B-PP	O
RRR	RRR	NN	B-NP	B-protein
nl	nl	NN	I-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
+	+	CC	O	O
S3	S3	NN	B-NP	O
abd	abd	NN	I-NP	O
benign	benign	JJ	I-NP	O
trace	trace	NN	I-NP	O
LEE	LEE	NN	I-NP	O
***	***	SYM	B-VP	O
EKG	EKG	NN	B-NP	B-protein
NSR	NSR	NN	I-NP	I-protein
-	-	HYPH	O	O
92	92	CD	B-NP	O
,	,	,	O	O
RBBB	RBBB	NNP	B-NP	B-protein
,	,	,	O	O
TWI	TWI	NNP	B-NP	O
V5-V6	V5-V6	NNP	I-NP	O
Echo	Echo	NNP	I-NP	O
10/24	10/24	CD	I-NP	O
-	-	HYPH	I-NP	O
LV	LV	NN	I-NP	O
20-30	20-30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
regional	regional	JJ	B-NP	O
WMA	WMA	NN	I-NP	O
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
Cath	Cath	NN	I-NP	O
4/3	4/3	CD	I-NP	O
-	-	HYPH	I-NP	O
R	R	NN	I-NP	O
dom	dom	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
sig	sig	NN	I-NP	O
LM	LM	NN	I-NP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	O
prox	prox	NN	I-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
IVUS	IVUS	VBZ	B-VP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
lumen	lumen	NN	B-NP	B-protein
diameter	diameter	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
X	X	SYM	I-NP	I-protein
1.4	1.4	CD	I-NP	I-protein
,	,	,	O	O
successful	successful	JJ	B-NP	O
stenting	stente	VBG	I-NP	O
LAD	LAD	NN	I-NP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
no	no	DT	B-NP	O
sig	sig	NN	I-NP	B-protein
LCX	LCX	NN	I-NP	I-protein
dz	dz	NN	I-NP	I-protein
,	,	,	O	O
RCA	RCA	NN	B-NP	B-protein
CXR	CXR	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
CT	CT	NN	B-NP	B-protein
PE	PE	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
Large	Large	JJ	I-NP	O
L	L	NN	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
mass	mass	NN	I-NP	O
,	,	,	O	O
subsegmental	subsegmental	JJ	B-NP	O
PE	PE	NN	I-NP	O
Trop	Trop	NN	I-NP	O
0.17	0.17	CD	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
0.30	0.30	CD	I-NP	O
-	-	HYPH	I-NP	O
>	>	SYM	I-NP	O
0.43	0.43	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
med	me	VBN	I-NP	O
management	management	NN	I-NP	O
only	only	RB	B-ADVP	O
,	,	,	O	O
stop	stop	VB	B-VP	O
trending	trend	VBG	I-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
***	***	SYM	I-NP	O
Impression	Impression	NN	I-NP	O
:	:	:	O	O
73	73	CD	B-NP	O
yo	yo	NN	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
ICM	ICM	NN	B-NP	B-protein
with	with	IN	B-PP	O
heart	heart	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
+	+	SYM	B-NP	O
PE	PE	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
?	?	.	O	O

leading	lead	VBG	B-VP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
to	to	TO	B-PP	O
heart	heart	NN	B-NP	B-protein
failure	failure	NN	I-NP	I-protein
exacerbation	exacerbation	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
CV	CV	NN	I-NP	B-protein
-	-	HYPH	B-NP	I-protein
P	P	NN	I-NP	I-protein
-	-	HYPH	O	O
ICMP	ICMP	NN	B-NP	B-protein
with	with	IN	B-PP	O
volume	volume	NN	B-NP	B-protein
overload	overload	NN	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
diuresis	diuresis	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
twice	twice	JJ	I-NP	I-protein
home	home	NN	I-NP	I-protein
dose	dose	NN	I-NP	I-protein
torsemide	torsemide	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
with	with	IN	B-PP	O
successful	successful	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
to	to	TO	B-PP	O
weight	weight	NN	B-NP	O
of	of	IN	B-PP	O
69.5	69.5	CD	B-NP	O
to	to	TO	I-NP	O
67.1	67.1	CD	I-NP	O
kg	kg	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
at	at	IN	B-PP	O
lower	low	JJR	B-NP	O
weight	weight	NN	I-NP	O
became	become	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
-	-	HYPH	B-NP	O
cont	cont	NN	I-NP	O
send	send	NN	I-NP	O
on	on	IN	B-PP	O
previous	previous	JJ	B-NP	O
home	home	NN	I-NP	O
diuretic	diuretic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	I-NP	O
same	same	JJ	I-NP	O
HTN	HTN	NN	I-NP	O
meds	med	NNS	I-NP	O
with	with	IN	B-PP	O
decrease	decrease	NN	B-NP	O
of	of	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
-	-	HYPH	I-NP	O
re	re	NN	I-NP	O
:	:	:	O	O
PE	PE	NN	B-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
no	no	DT	B-NP	O
RV	RV	NN	I-NP	O
strain	strain	NN	I-NP	O
on	on	IN	B-PP	O
echo	echo	NN	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
and	and	CC	I-NP	O
EKG	EKG	NN	I-NP	B-protein
,	,	,	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
treatment	treatment	NN	B-NP	O
dose	dose	NN	I-NP	O
lovenox	lovenox	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
transition	transition	NN	B-NP	O
to	to	TO	B-PP	O
coumadin	coumadin	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
goal	goal	NN	B-NP	B-protein
INR	INR	NN	I-NP	I-protein
2-3	2-3	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
indefinitely	indefinitely	RB	B-ADVP	O
-RRB-	-RRB-	SYM	B-NP	O
-	-	HYPH	B-NP	O
I	I	NN	I-NP	O
-	-	HYPH	B-NP	O
CAD	CAD	NN	I-NP	B-protein
with	with	IN	B-PP	O
trop	trop	NN	B-NP	O
leak	leak	NN	I-NP	O
-	-	HYPH	B-NP	O
combo	combo	NN	I-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
+	+	SYM	B-NP	O
PE	PE	NN	I-NP	O
?	?	.	O	O

-	-	HYPH	B-NP	O
cont	cont	NN	I-NP	O
ASA	ASA	NN	I-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
on	on	IN	B-PP	O
Rx	Rx	NN	B-NP	O
dose	dose	NN	I-NP	O
lovenox	lovenox	NN	I-NP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
BB	BB	NN	B-NP	B-protein
,	,	,	O	O
nitrate	nitrate	NN	B-NP	O
.	.	.	O	O

Recheck	Recheck	NN	B-NP	O
in	in	IN	B-PP	O
am	am	NN	B-NP	O
-	-	HYPH	B-NP	O
mild	mild	JJ	I-NP	O
bump	bump	NN	I-NP	O
again	again	RB	B-ADVP	O
.17	.17	CD	B-NP	O
to	to	TO	B-PP	O
0.30	0.30	CD	B-NP	O
to	to	TO	B-PP	O
0.43	0.43	CD	B-NP	O
-	-	HYPH	B-ADVP	O
given	give	VBN	B-PP	O
overall	overall	JJ	B-NP	O
picture	picture	NN	I-NP	O
with	with	IN	B-PP	O
advanced	advance	VBN	B-NP	O
lung	lung	NN	I-NP	O
CA	CA	NN	I-NP	O
,	,	,	O	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
recath	recath	VB	I-VP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
continued	continue	VBN	B-NP	O
optimal	optimal	JJ	I-NP	O
medical	medical	JJ	I-NP	O
management	management	NN	I-NP	O
-	-	HYPH	B-NP	O
R	R	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
tele	tele	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
no	no	DT	B-NP	O
issues	issue	NNS	I-NP	B-protein
2	2	CD	B-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
Onc	Onc	NN	I-NP	B-protein
-	-	HYPH	B-VP	O
currently	currently	RB	I-VP	O
undergoing	undergo	VBG	I-VP	O
XRT	XRT	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
continued	continue	VBN	B-VP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
primary	primary	JJ	B-NP	O
oncologist	oncologist	NN	I-NP	O
Dr.	Dr.	NNP	B-NP	O
Socia	Socia	NNP	I-NP	O
,	,	,	O	O
aware	aware	JJ	B-ADJP	O
,	,	,	O	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
again	again	RB	B-ADVP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
HEME	HEME	NN	I-NP	B-protein
-	-	HYPH	O	O
subsegmental	subsegmental	JJ	B-NP	O
PE	PE	NN	I-NP	O
-	-	HYPH	B-NP	O
lovenox	lovenox	NN	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
bridge	bridge	NN	B-NP	O
to	to	TO	B-PP	O
coumadin	coumadin	NN	B-NP	B-protein
DNR	DNR	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
DNI	DNI	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
have	have	VBP	B-VP	O
several	several	JJ	B-NP	O
changes	change	NNS	I-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
are	be	VBP	B-VP	O
now	now	RB	I-VP	O
only	only	RB	I-VP	O
taking	take	VBG	I-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Lisinopril	Lisinopril	NNP	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
now	now	RB	I-VP	O
taking	take	VBG	I-VP	O
Coumadin	Coumadin	NN	B-NP	O
3mg	3mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
the	the	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
will	will	MD	B-VP	O
tell	tell	VB	I-VP	O
you	you	PRP	B-NP	O
how	how	WRB	B-ADVP	O
to	to	TO	B-VP	O
adjust	adjust	VB	I-VP	O
your	your	PRP$	B-NP	O
dose	dose	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
lovenox	lovenox	NN	B-NP	B-protein
80	80	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
twice	twice	RB	B-ADVP	I-protein
daily	daily	RB	I-ADVP	I-protein
-LRB-	-LRB-	-LRB	I-ADVP	I-protein
you	you	PRP	B-NP	O
will	will	MD	B-VP	O
stop	stop	VB	I-VP	O
these	these	DT	B-NP	O
injections	injection	NNS	I-NP	O
when	when	WRB	B-ADVP	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
told	tell	VBN	I-VP	O
to	to	TO	B-PP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
coumadin	coumadin	NN	I-NP	B-protein
clinic	clinic	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
other	other	JJ	B-NP	O
worrisome	worrisome	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
seek	seek	JJ	B-NP	O
medical	medical	JJ	I-NP	O
attention	attention	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
Cont	Cont	NNP	I-NP	O
lovenox	lovenox	NN	I-NP	O
-	-	HYPH	I-NP	O
Have	Have	NN	I-NP	B-protein
INR	INR	NN	I-NP	I-protein
checked	check	VBD	B-VP	O
on	on	IN	B-PP	O
Thursday	Thursday	NNP	B-NP	O
by	by	IN	B-PP	O
VNA	VNA	NNP	B-NP	O
nurse	nurse	NN	I-NP	O
,	,	,	O	O
results	result	NNS	B-NP	O
to	to	TO	B-PP	O
An-peake	An-peake	NNP	B-NP	O
Rieale	Rieale	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Coumadin	Coumadin	NNP	I-NP	O
clinic	clinic	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
adjust	adjust	VB	I-VP	O
coumadin	coumadin	NN	B-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
STHILAIRE	STHILAIRE	NN	B-NP	O
,	,	,	O	O
FRANCES	FRANCES	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
KR30	KR30	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/12/06	7/12/06	CD	I-NP	O
@	@	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
05	05	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

